Variable No EACA (N = 17) EACA (N  = 113)  P
Mean ± SD Median Mean ± SD Median
Age 51.0 ± 15.0 57.3 55.9  ± 10.2 57.3 0.207
Duration (hours) 5.83 ± 2.67 5.83 6.71 ± 1.81 6.33 0.041
Initial Fib 273.3 ± 134.3 239.0 195.0± 84.1 172.0 0.024
Post Fib 193.9 ± 57.7 175.0 186.7 ± 44.7 180.0 0.835
Change in Fib 79.4 ± 119.7 80.0 8.46 ± 87.76 1.00 0.008
Initial Creatinine 2.02 ± 3.09 1.30 1.54 ± 1.03 1.20 0.855
Initial Tbili 11.73 ± 12.07 6.60 8.02 ± 8.33 5.40 0.487
Initial INR 1.92 ± 0.77 1.72 1.92 ± 0.82 1.76 0.617
RBCs 896.1 ± 592.8 1050 3224 ± 2864 2400 <0.001
MELD score 22.60 ± 6.20 20.29 22.35 ± 6.18 20.8 0.893
Categorical Variables n of N=17 % No EACA n of N=113 % EACA p
Sex (% Male) 11 64.7% 68 60.2% 0.721
RBCs 14 82.4% 105 92.9% 0.157
Cell Saver 0 0.00% 8 7.08% 0.596
FFP 12 70.6% 106 93.8% 0.010
Platlets 4 23.5% 78 69.0% <0.001
Factor 7 4 23.5% 12 10.6% 0.225
Liver & Kidney 2 11.8% 15 13.3% 1.000
Retransplant 1 5.88% 11 9.73% 1.000
Thrombus 2 11.8% 6 5.31% 0.281
Mortality 1 5.88% 3 2.65% 0.433
Table 4: Characteristics of the participants with MELD >15 by procedure.